Review article · 2000

Antineoplastic agents from natural sources: achievements and future directions

Gordon M. L. Cragg, David J. Newman

Expert Opinion on Investigational Drugs, 9(12), 2783–2797 · Published 1 December 2000 · DOI 10.1517/13543784.9.12.2783

View at the publisherCite this paper

In brief

“Antineoplastic agents from natural sources: achievements and future directions” is a 2000 review article by Gordon M. L. Cragg and David J. Newman, published in Expert Opinion on Investigational Drugs. OpenAlex counts 193 citations as of 15 November 2026, which puts it in the top 5% of works published in 2000 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
193
Most cited in
2019 (14)
Field-weighted impact
0.39
References
75
Authors
2

Abstract

The influence of natural products upon anticancer drug discovery and design cannot be overestimated. Approximately 60% of all drugs now in clinical trials for the multiplicity of cancers are either natural products, compounds derived from natural products, contain pharmacophores derived from active natural products or are 'old drugs in new clothes', where (modified) natural products… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cragg, G. M. L., & Newman, D. J. (2000). Antineoplastic agents from natural sources: achievements and future directions. Expert Opinion on Investigational Drugs, 9(12), 2783–2797. https://doi.org/10.1517/13543784.9.12.2783

MLA 9

Cragg, Gordon M. L., and David J. Newman. “Antineoplastic agents from natural sources: achievements and future directions.” Expert Opinion on Investigational Drugs, vol. 9, no. 12, 2000, pp. 2783–2797. https://doi.org/10.1517/13543784.9.12.2783.

Chicago

Cragg, Gordon M. L. and David J. Newman. 2000. “Antineoplastic agents from natural sources: achievements and future directions.” Expert Opinion on Investigational Drugs 9 (12): 2783–2797. https://doi.org/10.1517/13543784.9.12.2783.

Harvard

Cragg, G. M. L. and Newman, D. J. (2000) ‘Antineoplastic agents from natural sources: achievements and future directions’, Expert Opinion on Investigational Drugs, 9(12), pp. 2783–2797. doi:10.1517/13543784.9.12.2783.

IEEE

G. M. L. Cragg and D. J. Newman, “Antineoplastic agents from natural sources: achievements and future directions,” Expert Opinion on Investigational Drugs, vol. 9, no. 12, pp. 2783–2797, 2000, doi: 10.1517/13543784.9.12.2783.

BibTeX

@article{cragg2000antineoplastic,
  title     = {{Antineoplastic agents from natural sources: achievements and future directions}},
  author    = {Cragg, Gordon M. L. and Newman, David J.},
  journal   = {Expert Opinion on Investigational Drugs},
  year      = {2000},
  volume    = {9},
  number    = {12},
  pages     = {2783--2797},
  doi       = {10.1517/13543784.9.12.2783},
  url       = {https://doi.org/10.1517/13543784.9.12.2783}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201788
201888
20191414
20201212
202177
20221111
20231212
202433
202555
202633

Its field-weighted citation impact is 0.39: it has been cited 0.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds

  • anticancer agents
  • natural products
  • anticancer drug discovery
  • anticancer drug design
  • clinical trials
  • cancer chemotherapy
  • chemotypes
  • pharmacophore

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Cragg, G. M. L., & Newman, D. J. (2000). Antineoplastic agents from natural sources: achievements and future directions. Expert Opinion on Investigational Drugs, 9(12), 2783–2797. https://doi.org/10.1517/13543784.9.12.2783

How many times has this paper been cited?

193 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Gordon M. L. Cragg, David J. Newman.

What is the DOI of this paper?

10.1517/13543784.9.12.2783. The permanent link is https://doi.org/10.1517/13543784.9.12.2783.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.